Drug Insights

Is Tadalafil/finasteride approved by the FDA?

18 July 2024
3 min read

Yes, tadalafil and finasteride (Entadfi) is FDA approved. The combination of these two drugs was approved by the FDA to treat signs and symptoms of BPH, providing relief for men with an enlarged prostate.

Uses

Tadalafil and finasteride are used together to alleviate the symptoms of BPH, a condition characterized by an enlarged prostate gland. This combination helps to improve urine flow and reduce symptoms such as difficulty in starting urination and the need to urinate frequently or urgently.

Dosage

The usual adult dosage for treating BPH with tadalafil and finasteride is one capsule (containing 5 mg of tadalafil and 5 mg of finasteride) taken orally once daily. The capsule should be taken without food at approximately the same time each day, and the treatment duration is up to 26 weeks.

Administration Instructions

  • Follow Prescription: Take the medication exactly as prescribed by your doctor. Do not take more than one dose per day.
  • Missed Dose: If you miss a dose, take it as soon as possible, but do not take more than one dose per day.
  • Storage: Store the medication at room temperature away from moisture and heat.

Warnings and Precautions

  • Nitrate Medications: Do not take tadalafil and finasteride with nitrate medications (e.g., nitroglycerin) or recreational drugs containing nitrates (e.g., "poppers"), as this can cause a sudden and serious decrease in blood pressure.
  • Pregnancy: This medication is not for use in women and can cause birth defects if a woman is exposed to it during pregnancy. Pregnant women should not handle crushed or open capsules.
  • Allergies: Inform your doctor if you have any allergies to tadalafil, finasteride, or any other medications.
  • Pre-existing Conditions: Disclose any history of heart problems, pulmonary hypertension, liver or kidney disease, vision or hearing issues, bleeding problems, or any deformities of the penis to your doctor.

Side Effects

Common side effects of tadalafil and finasteride may include:

  • Headache
  • Indigestion
  • Back pain
  • Muscle aches
  • Loss of interest in sex, impotence
  • Enlarged or painful breasts
  • Stuffy or runny nose
  • Flushing (sudden warmth, redness, or tingly feeling)

Serious side effects requiring immediate medical attention include:

  • Allergic reactions (hives, difficult breathing, swelling in the face or throat)
  • Severe skin reactions (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling)
  • Heart attack symptoms (chest pain or pressure, pain spreading to the jaw or shoulder, nausea, sweating)
  • Painful or prolonged erection lasting longer than 4 hours
  • Breast lumps or pain, nipple discharge
  • Ringing in the ears or sudden hearing loss
  • Vision changes or sudden vision loss

Drug Interactions

Tadalafil and finasteride can interact with various medications. It is crucial to inform your doctor about all your current medications, including prescription and over-the-counter drugs, vitamins, and herbal products. Notably, avoid taking this medication with:

  • Medicines for pulmonary arterial hypertension (e.g., riociguat)
  • Other drugs for erectile dysfunction or BPH
  • Certain antibiotics, antifungal medications, and HIV/AIDS treatments

Conclusion

Tadalafil and finasteride (Entadfi) is an FDA-approved medication for the treatment of benign prostatic hyperplasia (BPH) in men. It effectively relieves symptoms associated with an enlarged prostate. However, it should be used with caution, considering potential side effects and interactions with other medications. Always consult your healthcare provider for personalized advice and treatment plans.

How to obtain the latest development progress of all drugs?

In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Rznomics Inc. Receives Australian Approval for Clinical Trial on RNA Editing Therapy in Retinitis Pigmentosa, Targeting RHO Gene
Latest Hotspot
3 min read
Rznomics Inc. Receives Australian Approval for Clinical Trial on RNA Editing Therapy in Retinitis Pigmentosa, Targeting RHO Gene
18 July 2024
Rznomics Inc. Gains Approval in Australia for Clinical Trial of RNA Editing Therapy Targeting RHO Gene in Retinitis Pigmentosa.
Read →
Is Pafolacianine approved by the FDA?
Drug Insights
3 min read
Is Pafolacianine approved by the FDA?
18 July 2024
Pafolacianine received FDA approval on November 29, 2021. This approval has provided surgeons with a novel tool to enhance the visualization of ovarian cancer lesions, thereby improving surgical outcomes.
Read →
Cytonics Initiates Phase 1 Trial of CYT-108 for Knee Osteoarthritis
Latest Hotspot
3 min read
Cytonics Initiates Phase 1 Trial of CYT-108 for Knee Osteoarthritis
18 July 2024
Cytonics Reveals Start Of Initial Human Phase 1 Trial For CYT-108 In Individuals With Knee Osteoarthritis.
Read →
Is Maribavir approved by the FDA?
Drug Insights
2 min read
Is Maribavir approved by the FDA?
17 July 2024
Maribavir received FDA approval on November 23, 2021. This approval provides a new treatment option for post-transplant patients dealing with refractory CMV infections.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.